Reimbursement gaps and inconsistent complication reporting might be slowing the adoption of neuraxial ultrasound. Will Mauldin, Ph.D. — Chairman, CEO, and Co‑founder at RIVANNA — explains why these systemic challenges must be addressed to ensure advanced ultrasound technology reaches its full potential in labor and delivery settings.
Standardizing complication reporting and aligning reimbursement policies with innovation are critical next steps for improving patient outcomes. 🔔 Follow us to stay informed on the latest in neuraxial ultrasound.